13D Filing: Baker Bros. Advisors and Idera Pharmaceuticals Inc. (IDRA)

Page 9 of 10

Page 9 of 10 – SEC Filing

CUSIP No.   45168K306   Page   9   of   10   Pages
ITEM 6. Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer.

Item 6 of Amendment No. 2 is supplemented and superseded, as
the case may be, as follows:

The disclosure in Items 4 and 5 is incorporated herein by reference.

The Voting Agreement is incorporated by reference as Exhibit
99.1 hereto and is incorporated by reference herein.

ITEM
7.
Material
to Be Filed as Exhibits.

 

Exhibit Description
99.1 Voting and Support Agreement, dated as of January 21, 2018, by and between Idera Pharmaceuticals, Inc., 667, L.P. and Baker Brothers Life Sciences, L.P. (incorporated by reference to Exhibit 99.1 to the Issuer’s Current Report on Form 8-K, filed with the SEC on January 22, 2018).

Follow Aceragen Inc. (NASDAQ:ACGN)

Page 9 of 10